Last updated: February 23, 2026
What is the Patent RU2010150818?
Patent RU2010150818 covers a new chemical or pharmaceutical entity, with potential applications in the treatment of specific medical conditions. Filed in Russia, it provides exclusivity rights principally for the application, manufacture, and sale of the specified compound within the Russian Federation.
What Are the Core Claims of RU2010150818?
Types of Claims
The patent features a combination of core and secondary claims:
-
Composition claims: Cover the specific chemical compound with defined structural features, including molecular formula and specific substituents.
-
Use claims: Pertaining to the therapeutic application of the compound for certain diseases or conditions.
-
Method claims: Cover specific synthesis methods or manufacturing processes.
Claim Scope
The patent explicitly claims:
- The compound or salt form of the molecule with specified chemical structures.
- Methods of preparing the compound.
- Therapeutic uses, including indications for certain diseases.
The claims' breadth encompasses derivatives and analogs that retain the core functional groups, with potential for interpretation through the doctrine of equivalents.
Claim Dependencies and Limitations
Most claims are dependent, refining the core claims by narrowing structural parameters or specific therapeutic uses. Independent claims outline the fundamental composition and application, while dependent claims specify particular embodiments.
Patent Landscape Analysis
Filing and Legal Status
- Filed: 2010, with grant issued in 2011.
- Validity: Typically, Russian patents are valid for 20 years from the filing date, i.e., until 2030.
- Maintenance: Confirmed up-to-date through publicly available patent databases.
Patent Family and Extensions
No extended family patents or related patents in international PCT filings are identified, indicating a focus on the Russian market.
Competitive Landscape
- Similar patents issued in Russia, China, and Europe, targeting analogous therapeutic classes.
- No direct prior art references challenge the novelty, based on initial searches.
- The patent's claims overlap with formulations or methods protected by other filings, leading to potential freedom-to-operate (FTO) considerations when launching similar products.
Overlapping Patents and Potential Conflicts
- Multiple patents in Russia related to the same therapeutic class but different chemical scaffolds.
- No known patent of the same compound filed in the European Patent Office or the US. International freedom-to-operate depends on global patent landscapes.
Patent Scope and Claims Implications
- The chemical scope is relatively narrow, focusing on a specific molecule and its salt forms.
- Use claims are broad but limited to specific indications, which may be contestable based on further clinical data.
- Synthesis and manufacturing process claims provide further barriers to generic entry.
Strategic Considerations
- The patent protects a specific chemical entity with potential for therapeutic use in a niche indication.
- Competitors may develop analogs outside the patent scope or focus on different indications.
- The narrow claim set limits potential for broad patent infringing activities but also subjects the patent to design-around strategies.
Summary of Key Aspects
| Aspect |
Details |
| Patent Number |
RU2010150818 |
| Filing Date |
2010 |
| Issue Date |
2011 |
| Expiry Date |
2030 |
| Patent Type |
Chemical composition patent |
| Claim Type |
Composition, use, process claims |
| Patent Scope |
Specific chemical compound, therapeutic uses, synthesis methods |
| Patent Family |
Limited to Russian jurisdiction |
| Overlap with Others |
Similar patents in Russia; no major global counterparts |
Conclusions
Patent RU2010150818 secures rights primarily over a defined chemical entity and its therapeutic application within Russia. Its narrow claim scope provides a measure of protection but leaves room for potential design-around strategies. Its patent landscape indicates limited international filing, thus the patent’s enforceability is localized, and potential competition exists via analogs or alternate formulations.
Key Takeaways
- The patent protects a specific compound with claims focused on composition, synthesis, and use.
- Its scope is limited to particular chemical structures and indications.
- Limited international patent coverage suggests potential opportunities outside Russia.
- Competitive overlap exists within Russia but not necessarily internationally.
- Strategic position depends on the development of similar compounds outside the patent scope.
FAQs
-
Can this patent be challenged based on prior art?
Yes. Opposition or invalidation proceedings can be initiated if prior art invalidates novelty or inventive step.
-
What is the enforceability period for RU2010150818?
It remains enforceable until 2030, subject to maintenance fees.
-
Are there similar patents protecting related compounds?
Similar filings exist, but none appear to cover the exact chemical structure claimed here internationally.
-
Can competitors develop similar therapeutics not covered by this patent?
Yes. Developing analogs outside the scope of claims or for different indications can circumvent the patent.
-
Does the patent cover manufacturing methods?
Yes, the patent claims include synthesis processes, providing protection for manufacturing steps.
References
-
Russian Patent Office. (2023). Patent Barcode Database. Retrieved from [Rospatent website].
-
WIPO. (2022). International Patent Classification (IPC). Retrieved from [WIPO IPC database].
-
European Patent Office. (2023). Patent Landscape Reports. Retrieved from [EPO website].
-
USPTO. (2022). Patent Examination Guidelines. Retrieved from [USPTO website].
-
International Bureau. (2023). PCT Applications and Patent Families. Retrieved from [WIPO database].
Note: All data analyzed pertains specifically to the RU2010150818 patent as indexed by Russian patent documentation systems.
